Xtant Medical Holdings, Inc.
XTNT
$0.36
-$0.02-6.26%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -34.96% | -36.53% | 2.68% | 19.04% | 18.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -34.96% | -36.53% | 2.68% | 19.04% | 18.26% |
| Cost of Revenue | -12.82% | -29.60% | -5.72% | -3.16% | -2.06% |
| Gross Profit | -45.11% | -40.86% | 10.80% | 34.86% | 30.69% |
| SG&A Expenses | -11.99% | -22.83% | 4.92% | -2.92% | -8.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.65% | -25.23% | -0.28% | -3.15% | -6.39% |
| Operating Income | -190.16% | -374.98% | 49.84% | 167.28% | 256.96% |
| Income Before Tax | -345.47% | -9,378.79% | 150.83% | 131.54% | 199.48% |
| Income Tax Expenses | -71.37% | 208.00% | 7,238.10% | 314.52% | 608.33% |
| Earnings from Continuing Operations | -365.15% | -5,425.86% | 101.80% | 126.04% | 191.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -365.15% | -5,425.86% | 101.80% | 126.04% | 191.95% |
| EBIT | -190.16% | -374.98% | 49.84% | 167.28% | 256.96% |
| EBITDA | -163.20% | -211.79% | 219.21% | 236.91% | 397.38% |
| EPS Basic | -363.14% | -5,625.00% | 102.00% | 125.27% | 186.15% |
| Normalized Basic EPS | -343.27% | -13,800.00% | 39.52% | 130.43% | 192.93% |
| EPS Diluted | -450.00% | -5,625.00% | 100.00% | 123.50% | 166.67% |
| Normalized Diluted EPS | -360.00% | -13,800.00% | 43.55% | 128.26% | 186.96% |
| Average Basic Shares Outstanding | 0.68% | 0.71% | -11.64% | 3.41% | 6.94% |
| Average Diluted Shares Outstanding | -5.60% | -2.29% | -4.92% | 11.31% | 14.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |